Title
Chronic kidney disease prevalence in Rivas, Nicaragua: use of a field device for creatinine measurement
UMMS Affiliation
School of Medicine; Senior Scholars Program
Faculty Mentor
Ryan Ferguson (Boston University School of Public Health)
Publication Date
2015-04-01
Document Type
Article
Subjects
Creatinine; Female; Humans; Male; Nicaragua; Point-of-Care Systems; Prevalence; Renal Insufficiency, Chronic; Sensitivity and Specificity
Disciplines
Diagnosis | Female Urogenital Diseases and Pregnancy Complications | Male Urogenital Diseases | Medical Biochemistry | Nephrology
Abstract
OBJECTIVE: An epidemic of chronic kidney disease (CKD) has been identified in Pacific coastal regions of Central America, and screening in the field in these low income countries remains logistically problematic. We tested the performance characteristics of a point of care creatinine analyzer compared to standardized serum creatinine measurements.
METHODS: Measurements were conducted in 100 persons from a local health center (n=34) and hospital (n=66) in Rivas, Nicaragua using both a point-of-care analyzer (StatSensor Xpress, Nova Biomedical) and serum creatinine by Jaffe kinetic method with a Roche Cobas Integra 400 analyzer. Percent coefficient of variation, sensitivity and specificity of the StatSensor Xpress were determined.
RESULTS: The average coefficient of variation (CV) was 1.28% for the serum creatinine and CV for the StatSensor Xpress analyzer was 6.8%. The median intra-individual creatinine results obtained with the StatSensor Xpress device were 0.32 mg/dL higher than those by serum creatinine by Jaffe kinetic method. The sensitivity and specificity of the StatSensor Xpress device for identifying subjects with abnormal creatinine (defined as > 1.2 mg/dL) was 100% and 79%, respectively.
CONCLUSIONS: Point of care testing for creatinine demonstrated acceptable repeatability, excellent sensitivity (100%) and modest specificity (79%). Using the point of care testing will allow for generalized screening in the field in low income countries; however, confirmation for elevated levels > 1.2 mg/dL will require a second laboratory test confirmation.
DOI of Published Version
10.1016/j.clinbiochem.2015.01.005
Source
Clin Biochem. 2015 Apr;48(6):456-8. doi: 10.1016/j.clinbiochem.2015.01.005. Epub 2015 Jan 21. Link to article on publisher's site
Journal/Book/Conference Title
Clinical biochemistry
Related Resources
PubMed ID
25617662
Repository Citation
Minnings K, Kerns E, Fiore M, Fiore M, Parekh RS, DuBois J, Isbell TS, Ferguson R, Fiore L. (2015). Chronic kidney disease prevalence in Rivas, Nicaragua: use of a field device for creatinine measurement. Senior Scholars Program. https://doi.org/10.1016/j.clinbiochem.2015.01.005. Retrieved from https://escholarship.umassmed.edu/ssp/219
Comments
Madeline Fiore participated in this study as a medical student as part of the Senior Scholars research program at the University of Massachusetts Medical School.